We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ion Beam Breakthrough Kills Tumors

By Biotechdaily staff writers
Posted on 09 Feb 2006
Nonsurgical cancer therapy that kills tumors but leaves healthy surrounding tissue intact could soon become available for patients if a recent study's results ultimately become reality. More...


The Los Alamos [U.S.] National Laboratory (NM, USA) Trident laser group, working with researchers from the University of Nevada, Reno (USA) and elsewhere, has succeeded in concentrating the intensity of a laser-driven carbon ion beam into a narrow range. This study supports earlier studies led by the University of Nevada that found much higher quality laser proton beams from laser acceleration as opposed to traditional particle acceleration.

Generating carbon ion beams and limiting their spread removes the primary hurdle to improving such applications as tumor irradiation therapy. Many technologic challenges still have to be met to develop a compact particle generator that could be utilized in a hospital environment. No clinical trials are impending. This new development, however, should create new opportunities for developments in nuclear fusion applications.

The study was published in the January 26, 2006, issue of the journal Nature.



Related Links:
University of Nevada, Reno

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
All-in-One Molecular System
AIO M160
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.